Article
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".
Thoracic cancer - 1 Feb 2024
Shigeta Naoko, Yokose Tomoyuki, Murakami Shuji, Isaka Tetsuya, Shinada Kanako, Yoshioka Emi, Narita Atsuya, Katakura Kengo, Kondo Tetsuro, Kato Terufumi, Nagashima Takuya, Saito Haruhiro, Ito Hiroyuki
Abstract excerpt
BACKGROUND: The terminology for lung cancer diagnosis in small biopsies was adopted in the 2015 World Health Organization classification. If non-small cell lung cancer (NSCLC) has no clear adenocarcinoma (AD) or squamous cell carcinoma morphology, the tumor is further classified based on mucin or immunohistochemical staining as NSCLC favor AD (NFAD), NSCLC favor squamous cell carcinoma, or NSCLC not otherwise...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.